de Salles, Manuel Casselholm
Epstein, David http://orcid.org/0000-0002-0399-3138
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 3 September 2020
Revised: 24 February 2021
Accepted: 2 March 2021
First Online: 18 March 2021
Declarations
:
: The study adhered to the tenets of the Declaration of Helsinki and the regional ethical review board in Stockholm approved the protocol.
: David Epstein has received lecture fees and participated in advisory boards for Allergan, Bayer and Novartis. Manuel Casselholm de Salles has no financial disclosures.